Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0000950170-24-061084

Options or other derivatives

  • Director acquired 22,646 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fairmount Funds Management LLC · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-05-14 Grant or award : show line 1 in the form Stock Option (Right to Buy) +11,323 11,323 I
2024-05-14 Grant or award : show line 2 in the form Stock Option (Right to Buy) +11,323 11,323 I
Loading xslF345X05/ownership.xml…